Catalyst Wire Dossier Catalyst Wire Dossier

Mynzepli

aflibercept · Advanz Pharma Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mynzepli, covering 2026-04-10 to 2026-04-10. Get the full timeline:

Most recent: EMA Authorised: Mynzepli (aflibercept) — Advanz Pharma Limited

See pricing